These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype. Aydin C, Oztan O, Isgor C. Behav Brain Res; 2011 Sep 23; 222(2):332-41. PubMed ID: 21497168 [Abstract] [Full Text] [Related]
4. Hippocampal Y2 receptor-mediated mossy fiber plasticity is implicated in nicotine abstinence-related social anxiety-like behavior in an outbred rat model of the novelty-seeking phenotype. Aydin C, Oztan O, Isgor C. Pharmacol Biochem Behav; 2014 Oct 23; 125():48-54. PubMed ID: 25158103 [Abstract] [Full Text] [Related]
6. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms. Chae Y, Yeom M, Han JH, Park HJ, Hahm DH, Shim I, Lee HS, Lee H. Neurosci Lett; 2008 Jan 10; 430(2):98-102. PubMed ID: 18060697 [Abstract] [Full Text] [Related]
7. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift? Caberlotto L, Rimondini R, Hansson A, Eriksson S, Heilig M. Neuropsychopharmacology; 2004 Jan 10; 29(1):15-22. PubMed ID: 12968131 [Abstract] [Full Text] [Related]
8. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Slawecki CJ, Thorsell AK, El Khoury A, Mathé AA, Ehlers CL. Neuropeptides; 2005 Aug 10; 39(4):369-77. PubMed ID: 16038974 [Abstract] [Full Text] [Related]
10. Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions. Theisen CC, Reyes BAS, Sabban EL, Van Bockstaele EJ. Neuroscience; 2018 Aug 01; 384():21-40. PubMed ID: 29775703 [Abstract] [Full Text] [Related]
11. Interactions between NPY and CRF in the amygdala to regulate emotionality. Sajdyk TJ, Shekhar A, Gehlert DR. Neuropeptides; 2004 Aug 01; 38(4):225-34. PubMed ID: 15337374 [Abstract] [Full Text] [Related]
12. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats. Yilmazer-Hanke DM, Hantsch M, Hanke J, Schulz C, Faber-Zuschratter H, Schwegler H. Neuroscience; 2004 Aug 01; 124(2):283-97. PubMed ID: 14980379 [Abstract] [Full Text] [Related]
13. Hippocampus modulates the behaviorally-sensitizing effects of nicotine in a rat model of novelty-seeking: potential role for mossy fibers. Bhatti AS, Hall P, Ma Z, Tao R, Isgor C. Hippocampus; 2007 Aug 01; 17(10):922-33. PubMed ID: 17598146 [Abstract] [Full Text] [Related]
18. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties. Husum H, Bolwig TG, Sánchez C, Mathé AA, Hansen SL. Epilepsy Behav; 2004 Apr 01; 5(2):204-15. PubMed ID: 15123022 [Abstract] [Full Text] [Related]
19. Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Sheriff S, Dautzenberg FM, Mulchahey JJ, Pisarska M, Hauger RL, Chance WT, Balasubramaniam A, Kasckow JW. Peptides; 2001 Dec 01; 22(12):2083-9. PubMed ID: 11786194 [Abstract] [Full Text] [Related]